Environmental

AVNS appears mid-pack on environmental intensity because R&D spend near 3.2% of revenue suggests some product stewardship focus, but peers in medtech often disclose broader climate programs.

Low leverage reduces balance-sheet pressure to fund environmental remediation, yet it does not by itself indicate stronger emissions or waste management than peers.

The provided metrics do not show material environmental disclosure on energy, water, or waste, leaving AVNS less transparent than better-disclosed peers on operational footprint.

No post-August 2025 evidence was provided for environmental incidents or targets, so the score reflects limited disclosed differentiation rather than confirmed environmental weakness.

Social

AVNS looks relatively solid on social factors because moderate R&D intensity supports ongoing product improvement, which is important in medical devices versus lower-investment peers.

Stock-based compensation at about 1.7% of revenue suggests manageable employee incentive costs, but it provides only limited evidence of stronger workforce alignment than peers.

The absence of provided data on recalls, patient safety events, or labor controversies prevents a higher score, yet no structural social disadvantage is evident versus peers.

In a regulated healthcare context, the available metrics imply steady stakeholder discipline, although peers with stronger safety and quality disclosure would still rank above AVNS.

Governance

AVNS shows comparatively disciplined governance because debt-to-equity of 0.18 indicates restrained leverage, reducing creditor pressure that can weaken oversight versus peers.

Net debt to EBITDA of -3.37 suggests a net cash position, which typically supports governance flexibility and lowers refinancing risk relative to more levered peers.

Stock-based compensation at 1.7% of revenue appears contained, implying less dilution pressure than peers with heavier equity-based pay practices.

The provided metrics do not reveal board independence, audit quality, or controversy history, so the score reflects favorable capital discipline rather than top-tier governance disclosure.

Overall Score

AVNS ranks above average overall because disciplined leverage and steady R&D support stronger governance and social positioning than many peers, despite limited environmental disclosure.

Score Driver: Net Cash-Like Leverage And Restrained Capital Structure